What is the typical dose of amiodarone (antiarrhythmic medication) for treating arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Dosing for Arrhythmias

The typical dosing regimen for amiodarone consists of a loading dose of 600-800 mg per day for atrial fibrillation or 800-1600 mg per day for ventricular arrhythmias until a total of 10g has been given, followed by a maintenance dose of 200-400 mg daily. 1

Dosing by Arrhythmia Type

Atrial Fibrillation

  • Loading phase: 600-800 mg daily in divided doses until a total of 10g has been given 1
  • Maintenance phase: 200-400 mg daily 1

Ventricular Arrhythmias

  • Loading phase: 800-1600 mg daily in divided doses until a total of 10g has been given 1
  • Alternative loading: 600 mg twice daily for 7 days (total 8.4g) 1
  • Maintenance phase: 200-400 mg daily 1

Conversion from IV to Oral Therapy

When transitioning from intravenous to oral amiodarone, adjust the oral loading dose based on the duration of previous IV therapy:

Duration of IV Use Recommended Oral Amiodarone Dose
<1 week 800-1600 mg daily
1-3 weeks 600-800 mg daily
>3 weeks 400 mg daily

1

Important Clinical Considerations

Dose Adjustments

  • Lower maintenance doses (100-400 mg daily) are generally effective for most arrhythmias while minimizing toxicity 1, 2
  • Consider patient-specific factors such as age, renal function, and hepatic function when determining dose 1
  • Dose reduction is often necessary due to side effects - in one study, the mean dose was reduced from 572 mg/day at 45 days to 372 mg/day at 6 months due to side effects 3

Monitoring Requirements

  • ECG monitoring every 3-6 months for QT interval prolongation 1
  • Thyroid function tests every 6 months 1
  • Liver function tests every 6 months 1
  • Pulmonary function tests if respiratory symptoms develop 1
  • Ophthalmologic examination annually if therapy continues beyond 1 year 1

Drug Interactions

  • Requires dose adjustments of concomitant medications due to CYP450 enzyme inhibition 1
  • Key interactions:
    • Warfarin: reduced clearance, monitor INR closely 1
    • Digoxin: levels may double 1
    • Statins: limit simvastatin to 20 mg daily 1

Common Side Effects and Toxicity

  • Side effects are dose-dependent and extremely common (93% of patients in one study) 3
  • Maintain potassium and magnesium levels >4.0 mEq/L before and during therapy 1
  • Major side effects include:
    • Gastrointestinal (especially constipation) 3
    • Corneal microdeposits (nearly universal) 3
    • Neurologic (tremor, ataxia) 3
    • Pulmonary toxicity (requires immediate attention) 3
    • Thyroid dysfunction 3
    • Cutaneous abnormalities 3

Clinical Pearls

  • Amiodarone has an extremely long half-life (15-100 days), resulting in:
    • Delayed onset of full therapeutic effect (90-150 days) 2
    • Persistent antiarrhythmic effects for up to 150 days after discontinuation 2
    • Need for tapering rather than abrupt discontinuation 1
  • Consider discontinuation after 6-12 months of arrhythmia-free period or if significant toxicity develops 1

References

Guideline

Amiodarone Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ten years of experience with amiodarone.

American heart journal, 1983

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.